Literature DB >> 16193064

Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8.

Soonah Shin1, Yoonmi Lee, Wooseok Kim, Hyeonseok Ko, Hyeyeon Choi, Kunhong Kim.   

Abstract

Although caspase-2 is believed to be involved in death receptor-mediated apoptosis, the exact function, mode of activation, and regulation of caspase-2 remain unknown. Here we show that protein kinase (PK) CK2 phosphorylates procaspase-2 directly at serine-157. When intracellular PKCK2 activity is low or downregulated by specific inhibitors, procaspase-2 is dephosphorylated, dimerized, and activated in a PIDDosome-independent manner. The activated caspase-2 then processes procaspase-8 monomers between the large and small subunits, thereby priming cancer cells for TNF-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis. The processed procaspase-8 that is recruited to death-inducing signaling complex by TRAIL engagement becomes fully activated, and cancer cells undergo apoptosis. PKCK2 activity is low in TRAIL-sensitive cancer cell lines but high in TRAIL-resistant cancer cell lines. Thus, downregulating PKCK2 activity is required for TRAIL-mediated apoptosis to occur in TRAIL-resistant cancer cells. Our data provide novel insights into the regulation, mode of activation, and function of caspase-2 in TRAIL-mediated apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16193064      PMCID: PMC1276710          DOI: 10.1038/sj.emboj.7600827

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  38 in total

1.  Activation of initiator caspases through a stable dimeric intermediate.

Authors:  Min Chen; Aaron Orozco; David M Spencer; Jin Wang
Journal:  J Biol Chem       Date:  2002-10-23       Impact factor: 5.157

2.  The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress.

Authors:  Antoine Tinel; Jürg Tschopp
Journal:  Science       Date:  2004-04-08       Impact factor: 47.728

3.  A unified model for apical caspase activation.

Authors:  Kelly M Boatright; Martin Renatus; Fiona L Scott; Sabina Sperandio; Hwain Shin; Irene M Pedersen; Jean Ehrland Ricci; Wade A Edris; Daniel P Sutherlin; Douglas R Green; Guy S Salvesen
Journal:  Mol Cell       Date:  2003-02       Impact factor: 17.970

Review 4.  Significance of protein kinase CK2 nuclear signaling in neoplasia.

Authors:  K Ahmed; A T Davis; H Wang; R A Faust; S Yu; S Tawfic
Journal:  J Cell Biochem Suppl       Date:  2000

5.  Caspase-2 is not required for thymocyte or neuronal apoptosis even though cleavage of caspase-2 is dependent on both Apaf-1 and caspase-9.

Authors:  L A O'Reilly; P Ekert; N Harvey; V Marsden; L Cullen; D L Vaux; G Hacker; C Magnusson; M Pakusch; F Cecconi; K Kuida; A Strasser; D C S Huang; S Kumar
Journal:  Cell Death Differ       Date:  2002-08       Impact factor: 15.828

6.  Ubiquitin-proteasome pathway as a primary defender against TRAIL-mediated cell death.

Authors:  S Kim; K Choi; D Kwon; E N Benveniste; C Choi
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

7.  Interdimer processing mechanism of procaspase-8 activation.

Authors:  David W Chang; Zheng Xing; Vanessa L Capacio; Marcus E Peter; Xiaolu Yang
Journal:  EMBO J       Date:  2003-08-15       Impact factor: 11.598

8.  Caspase-2 can function upstream of bid cleavage in the TRAIL apoptosis pathway.

Authors:  Klaus W Wagner; Ingo H Engels; Quinn L Deveraux
Journal:  J Biol Chem       Date:  2004-06-01       Impact factor: 5.157

9.  Phosphorylation by protein kinase CK2: a signaling switch for the caspase-inhibiting protein ARC.

Authors:  Pei-Feng Li; Jincheng Li; Eva-Christina Müller; Albrecht Otto; Rainer Dietz; Rüdiger von Harsdorf
Journal:  Mol Cell       Date:  2002-08       Impact factor: 17.970

10.  Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization.

Authors:  Patrice Lassus; Ximena Opitz-Araya; Yuri Lazebnik
Journal:  Science       Date:  2002-08-23       Impact factor: 47.728

View more
  52 in total

Review 1.  Emergence of protein kinase CK2 as a key target in cancer therapy.

Authors:  Janeen H Trembley; Zhong Chen; Gretchen Unger; Joel Slaton; Betsy T Kren; Carter Van Waes; Khalil Ahmed
Journal:  Biofactors       Date:  2010 May-Jun       Impact factor: 6.113

2.  In vitro reconstitution of the interactions in the PIDDosome.

Authors:  Tae-ho Jang; Chao Zheng; Hao Wu; Ju-Hong Jeon; Hyun Ho Park
Journal:  Apoptosis       Date:  2010-12       Impact factor: 4.677

Review 3.  Cellular mechanisms controlling caspase activation and function.

Authors:  Amanda B Parrish; Christopher D Freel; Sally Kornbluth
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-06-01       Impact factor: 10.005

Review 4.  Protein kinase CK2--a key suppressor of apoptosis.

Authors:  Kashif A Ahmad; Guixia Wang; Gretchen Unger; Joel Slaton; Khalil Ahmed
Journal:  Adv Enzyme Regul       Date:  2008-04-30

5.  Regulation of caspase pathways by protein kinase CK2: identification of proteins with overlapping CK2 and caspase consensus motifs.

Authors:  Jacob P Turowec; James S Duncan; Greg B Gloor; David W Litchfield
Journal:  Mol Cell Biochem       Date:  2011-07-13       Impact factor: 3.396

6.  Molecular characterization of apoptosis induced by CARF silencing in human cancer cells.

Authors:  C T Cheung; R Singh; A R Yoon; M K Hasan; T Yaguchi; S C Kaul; C O Yun; R Wadhwa
Journal:  Cell Death Differ       Date:  2010-11-05       Impact factor: 15.828

7.  Tumor-suppressing function of caspase-2 requires catalytic site Cys-320 and site Ser-139 in mice.

Authors:  Keqin Ren; Jing Lu; Aleksey Porollo; Chunying Du
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

Review 8.  Caspases: evolutionary aspects of their functions in vertebrates.

Authors:  K Sakamaki; Y Satou
Journal:  J Fish Biol       Date:  2009-03       Impact factor: 2.051

Review 9.  Protein kinase CK2 in health and disease: CK2: a key player in cancer biology.

Authors:  J H Trembley; G Wang; G Unger; J Slaton; K Ahmed
Journal:  Cell Mol Life Sci       Date:  2009-06       Impact factor: 9.261

10.  KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells.

Authors:  Ki Hyung Kim; Yanhua Xie; Ewan M Tytler; Richard Woessner; Gil Mor; Ayesha B Alvero
Journal:  J Transl Med       Date:  2009-07-20       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.